Subscribe To
Fsd pharma selected to present its phase 1 data on lucid-ms at msmilan 2023 – 9th joint ectrims-actrims meeting for october 11-13, 2023
Targeting the Approximate $22 Billion Multiple Sclerosis Drug Treatment Market TORONTO, ON / ACCESSWIRE / August 15, 2023 / FSD Pharma Inc. (NASDAQ:HU...
August 15, 2023, 7:30 am
89bio, inc.: a big bet on nash
89bio, Inc. is a clinical-stage biotech company focused on developing therapies for liver and cardio-metabolic...
August 10, 2023, 1:48 pm
Better therapeutics to release second quarter 2023 financial results and provide business update on august 09, 2023
SAN FRANCISCO--(BUSINESS WIRE)---- $BTTX #digitalhealth--Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therap...
August 2, 2023, 5:30 pm
Lly stock alert: what to know as eli lilly acquires versanis bio
Eli Lilly (NYSE: LLY ) stock is a hot topic among traders on Friday after the company announced its acquisition of Versanis Bio . Versanis Bio is a cl...
July 14, 2023, 10:29 am
Eli lilly to acquire versanis bio, expanding obesity-treatment pipeline
Eli Lilly and Co. LLY, -1.34% will acquire Versanis Bio, a private clinical-stage biopharma company focused on new treatments for cardio...
July 14, 2023, 8:14 am
Ani pharmaceuticals is undervalued when considering their unadvertised pipeline
ANIP Pharmaceuticals has not yet published a pipeline of products under development or out-licensed, leaving investors in the dark about future revenu...
July 5, 2023, 12:51 am
Reshape lifesciences® submits fda pma supplement application for the next-generation lap-band® 2.0
Enhanced Band Reservoir Technology Designed to Improve the Patient Experience IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — ReShape Lifesciences�...
June 26, 2023, 8:05 pm
Reviva pharmaceuticals to be added to russell microcap® index
CUPERTINO, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...
June 26, 2023, 10:00 am
Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model
Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...
June 24, 2023, 12:00 pm
Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at the 83rd american diabetes association scientific sessions
– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic contr...
June 24, 2023, 1:30 am
Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023
REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company ...
June 20, 2023, 4:30 pm
Altimmune to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest on tuesday, june 20th, 2023
GAITHERSBURG, Md., June 16, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that D...
June 16, 2023, 7:30 am
Panbela announces sponsored research agreement to evaluate polyamine metabolic inhibitor therapy in combination with car-t cell therapy
MINNEAPOLIS, June 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutic...
June 13, 2023, 12:15 pm
89bio shares rise as analysts see improved outlook for nash treatments
Shares of clinical-stage biopharma company 89bio Inc. ETNB, +4.38% gained 4.8% premarket on Tuesday as Evercore ISI analysts initiated coverage of the...
June 13, 2023, 8:29 am
Why shares of belite bio are slumping wednesday
Belite Bio is a clinical-stage biopharmaceutical company focusing on rare eye diseases and other metabolic...
May 31, 2023, 12:22 pm
Novo nordisk (nvo) collaborates for gene-editing therapies
Novo Nordisk (NVO) partners with Life Edit Therapeutics to discover and develop gene-editing therapies for rare and cardio...
May 24, 2023, 4:28 pm
Reviva pharmaceuticals joins webull corporate communications service platform
CUPERTINO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clini...
May 19, 2023, 10:30 am
Reviva pharmaceuticals to present at upcoming investor conferences in may 2023
CUPERTINO, Calif., May 18, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clini...
May 18, 2023, 10:30 am
Biorestorative therapies receives notice of allowance by the japanese patent and trademark office for a patent application related to its thermostem® program
—Upon issuance, patent will be the fourth Japanese patent to issue for the ThermoStem® program targeting obesity and ...
May 15, 2023, 11:00 am
Cardiometabolic disease market size worth usd 868.45 billion by 2032 at 24% cagr – report by market research future (mrfr)
Cardiometabolic Disease Market Trends and Insights By Treatment (Angiotensin-converting Enzyme (ACE) In...
May 10, 2023, 2:45 pm